A lab building in Burlington that traded for $103 million two years ago is back on the market, with expectations that it could sell at around a third of that price, if not lower.
When the global insurance giant MetLife bought the 109,000-square-foot Burlington BioCenter in November 2022, it was fully leased to three life sciences companies, Ultivue, ProtaGene and CANbridge. The building had just recently been converted from offices to labs.
Copyright Boston Business Journal
